10 Hep C Stocks on Wall Street's Watch List

Description:

According to Adam Feuerstein, "The end of the year will be a busy time for Hep C drug developers. Investors will be paying close attention to the third-quarter results from Vertex, watching to see if Incivek can maintain the scorching-fast start to its commercial launch." Read more here.

>>Also: 8 Biotech Stocks to Watch

>>Also: 5 Stocks Under $10 Setting Up to Trade Higher

Most Viewed Portfolios

View All

Articles

Hedge Funds Love These 5 Health Care Stocks -- but Should You?

04.23.14 | 12:59 PM

BALTIMORE (Stockpickr) -- The health care sector got a shot in the arm yesterday, buoyed by big M&A deals at a half dozen multi-billion drug stocks...

5 Stocks With Big Insider Buying

04.23.14 | 12:27 PM

DELAFIELD, Wis. (Stockpickr) -- Corporate insiders sell their own companies' stock for a number of reasons. >>5 Stocks Set to Soar on Bullish Ear...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter